Search results
Results From The WOW.Com Content Network
Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
This is a list of airports in Georgia (U.S. state), grouped by type and sorted by location.It contains all public-use and military airports in the state. Some private-use and former airports may be included where notable, such as airports that were previously public-use, those with commercial enplanements recorded by the FAA or airports assigned an IATA airport code.
Area code. 907. FIPS code. 02-01390. Alcan Border, also known as Port Alcan, is a census-designated place in the Southeast Fairbanks Census Area in the U.S. state of Alaska. Part of the Unorganized Borough, Alcan Border is the site of the Alcan - Beaver Creek Border Crossing, the main U.S. port of entry for persons arriving in Alaska by road.
The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.
Alcon relocated its headquarters to Geneva in 2018, citing an opportunity to “increase Alcon’s global scale and reach to better serve customers.” The company employs a total of 25,000 people.
In early 2023, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a new Alzheimer’s drug called Leqembi. (Biogen, a biotechnology company, and Eisai, a pharmaceutical ...
According to the 2010 United States census, Georgia was the 8th most populous state with 9,688,681 inhabitants and the 21st largest by land area spanning 57,513.49 square miles (148,959.3 km 2) of land. Georgia is divided into 159 counties and contains 535 municipalities consisting of cities, towns, consolidated city-counties, and consolidated ...
June 24, 2024 at 7:14 AM. (Reuters) - G1 Therapeutics said on Monday its drug for a rare, aggressive form of breast cancer did not meet the main goal of overall survival in a late-stage trial. G1 ...